Protagonist Therapeutics
PTGX
PTGX
81 hedge funds and large institutions have $164M invested in Protagonist Therapeutics in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
28% less capital invested
Capital invested by funds: $228M → $164M (-$64M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
81
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$12M | |
| 2 | +$4.44M | |
| 3 | +$3.38M | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$1.76M |
| 5 |
O
OrbiMed
New York
|
+$1.35M |
Top Sellers
| 1 | -$7M | |
| 2 | -$5.03M | |
| 3 | -$2.78M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.95M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.89M |